Written information about medicines for consumers

Knapp, Peter H.; Raynor, David K.; Nicolson, Donald; Blenkinsopp, Alison; Grime, Janet; Pollock, Kristian; Spoor, Pat; Gilbody, Simon; Maule, John; Dorer, Gill; Dickinson, David K.

doi:10.1002/14651858.cd002104.pub2

Cited by 2 publications

(2 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…26 A review under way, led by two of the authors (PK, DKR; for the Cochrane Consumers and Communication Group), has the title: 'Written information about medicines for consumers'. 28 This covers a restricted aspect of this review (knowledge and satisfaction are the primary outcome measures and the review only covers controlled trials, and no qualitative research). The Cochrane review by Haynes and colleagues on interventions to improve adherence to medication includes written medicines information interventions, but only in a much wider context.…”

Section: Existing Secondary Research Evidencementioning

confidence: 99%

A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines

Raynor¹,

Blenkinsopp²,

Knapp³

et al. 2007

Health Technol Assess

253

250

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTA NIHR Health Technology Assessment ProgrammeT he Health Technology Assessment (HTA) programme, now part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the costs, effectiveness and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined to include all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care, rather than settings of care. The research findings from the HTA Programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service'. The HTA Programme is needs-led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of projects. First is the commissioned route. Suggestions for research are actively sought from people working in the NHS, the public and consumer groups and professional bodies such as ...

show abstract

Section: Existing Secondary Research Evidencementioning

confidence: 99%

A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines

Raynor¹,

Blenkinsopp²,

Knapp³

et al. 2007

Health Technol Assess

253

250

View full text Add to dashboard Cite

show abstract

“…Medicines, especially those that are packaged for the patient, are by law required to come with information as represented in the Summary of Product Characteristics [1] . This should include the name of the drug, its form, how and when it should be administered and the frequency of administration.…”

Section: Introductionmentioning

confidence: 97%

The effect of advice to read the medicine/patient information leaflet among patients in Ghana: a cross-sectional study

Ankrah

Ofei

2010

Journal of Pharmaceutical Health Services Research

View full text Add to dashboard Cite

Objective Medicines, especially those that are packaged for the patient, are by law required to include a set of information. This informs the patient or client on his/her medication. Our aim was to investigate the factors that are associated with reading the medicine/patient information leaflet among patients who are advised to read the leaflet compared to those who are not, and to find out whether there are any significant differences between these two groups. Methods A total of 531 adult patients from the main teaching hospital in Accra, Ghana, were asked to fill in a questionnaire. Information was gathered with emphasis on those whose medication came with a leaflet. The effect of advice to read the leaflet and other associations between covariates were examined. Key findings Of the 531 patients, 421 (79.3%) had received a leaflet before and of these 93.8% had received some verbal information from the health worker (doctor/pharmacist/ nurse). Only 139/421 (33.0%) said they were ever told to read the leaflet by their health worker. Those who recalled being advised to read the leaflet were about six times (odds ratio = 5.77; 95% confidence interval (CI) 2.76–12.04; P < 0.001) as likely to report having read the leaflet than those who did not, and they were also more likely (59% compared with 36%; χ2 = 12.21; P < 0.001) to discuss with the health worker the problems they had while using the medication. Age group was a weak effect modifier (P = 0.04). Conclusions Educational status was the most important risk factor among those measured. Other risk factors were employment and marital status. Public awareness should be stepped up to encourage reading of the leaflet by patients.

show abstract

Written information about medicines for consumers

Cited by 2 publications

References 16 publications

A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines

A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines

The effect of advice to read the medicine/patient information leaflet among patients in Ghana: a cross-sectional study

Contact Info

Product

Resources

About